Will the vaccine value rally continue for investors?

There have been some clear winners and losers in the rebound from the stock market crash as coronavirus and lockdown hit.

Tech stars, companies with a  strong digital presence and those who have seen business increase as a result of lockdown – from B&Q-owner Kingfisher, to cycle and motoring store Halfords, and takeaway deliverer Just Eat - have been the only game in town.

But, as news of the most successful Covid-19 vaccine trials yet was revealed by Pfizer on Monday, there was a dramatic reversal of fortune: it was the companies beaten-down by lockdown that soared.

From aerospace engineer Rolls-Royce, to cinema operator Cineworld and travel-focussed caterer and retailer SSP, shares that had been languishing at lowly valuations and clouded by pessimism got a sudden dose of optimism.

So why did they rise so strongly, is this the much-heralded switch from growth to value investing and what does that even mean?

On this week’s podcast, Simon Lambert and Georgie Frost look at the vaccine rally, whether this marks a new chapter for investors and the economy… and what the risk of being disappointed again is.

Some investors hoping to take advantage this week couldn’t, however, as DIY investing platforms struggled under the weight of record days of trading from customers. Can those Hargreaves Lansdown, or other platform, clients try to claim any money back for trades missed?

Also on this week’s podcast, the potential capital gains tax raid being lined up – with perhaps some unintended consequences – and the surge of Curry’s PC World complains to This is Money.

And finally, the Government is soon expected to bring forward its ban on the sale of new petrol and diesel cars, with the favoured alternative being electric. 

But if you act now and go electric but don’t have a driveway for home charging is it practical – and can you take a lead across the pavement instead?